Puma Biotechnology
PBYI
PBYI
144 hedge funds and large institutions have $394M invested in Puma Biotechnology in 2019 Q3 according to their latest regulatory filings, with 35 funds opening new positions, 55 increasing their positions, 28 reducing their positions, and 30 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more ownership
Funds ownership: →
more funds holding
Funds holding: →
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
11% less capital invested
Capital invested by funds: $442M → $394M (-$48.4M)
18% less call options, than puts
Call options by funds: $6.45M | Put options by funds: $7.84M
Holders
144
Holding in Top 10
2
Calls
$6.45M
Puts
$7.84M
Top Buyers
| 1 | +$9.16M | |
| 2 | +$5.98M | |
| 3 | +$5.8M | |
| 4 |
MAM
Melqart Asset Management
London,
United Kingdom
|
+$5.7M |
| 5 |
FAM
Fred Alger Management
New York
|
+$5.16M |
Top Sellers
| 1 | -$19.3M | |
| 2 | -$7.2M | |
| 3 | -$3.33M | |
| 4 |
Renaissance Technologies
New York
|
-$3.21M |
| 5 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$3.12M |